199 related articles for article (PubMed ID: 35604531)
1. Clinical value of
Bai Z; Zhou T; Yu Z; Chen Y; Dong L
Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
[TBL] [Abstract][Full Text] [Related]
2. Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Lee J; Hyun SH; Kim S; Kim DK; Lee JK; Moon SH; Cho YS; Choe YS; Kim BT; Lee KH
Clin Nucl Med; 2016 May; 41(5):e237-43. PubMed ID: 26914555
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative
An SY; Sun BJ
BMC Cardiovasc Disord; 2024 Feb; 24(1):122. PubMed ID: 38389040
[TBL] [Abstract][Full Text] [Related]
6. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
Tokue A; Higuchi T; Arisaka Y; Nakajima T; Tokue H; Tsushima Y
Ann Nucl Med; 2015 Jul; 29(6):499-505. PubMed ID: 25877159
[TBL] [Abstract][Full Text] [Related]
7. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.
Zhang J; Chen H; Ma Y; Xiao Y; Niu N; Lin W; Wang X; Liang Z; Zhang F; Li F; Zhang W; Zhu Z
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1624-34. PubMed ID: 24764034
[TBL] [Abstract][Full Text] [Related]
8. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Ebbo M; Grados A; Guedj E; Gobert D; Colavolpe C; Zaidan M; Masseau A; Bernard F; Berthelot JM; Morel N; Lifermann F; Palat S; Haroche J; Mariette X; Godeau B; Bernit E; Costedoat-Chalumeau N; Papo T; Hamidou M; Harlé JR; Schleinitz N
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):86-96. PubMed ID: 23836437
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
11. Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.
Zhao Z; Wang Y; Guan Z; Jin J; Huang F; Zhu J
Clin Exp Rheumatol; 2016; 34(1):119-25. PubMed ID: 26842851
[TBL] [Abstract][Full Text] [Related]
12. Vascular/perivascular inflammation in IgG4-related disease.
Imai S; Tahara N; Igata S; Tahara A; Bekki M; Sugiyama Y; Maeda-Ogata S; Honda A; Otsuka H; Ushijima T; Okabe Y; Kaida H; Abe T; Tanaka H; Fukumoto Y; Tayama E
J Nucl Cardiol; 2022 Dec; 29(6):2920-2933. PubMed ID: 34704218
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT.
Pan Q; Luo Y; Zhang W
Clin Nucl Med; 2020 Apr; 45(4):312-313. PubMed ID: 31977476
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Bilateral orbital involvement of IgG4-related disease detected on 18F-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: A Clinical Case Report.
Dong P; Wang L; Li L
Medicine (Baltimore); 2019 Nov; 98(47):e18138. PubMed ID: 31764855
[TBL] [Abstract][Full Text] [Related]
18. Abnormal [
Nagahata K; Kanda M; Kamekura R; Sugawara M; Yama N; Suzuki C; Takano K; Hatakenaka M; Takahashi H
Ann Nucl Med; 2022 Feb; 36(2):200-207. PubMed ID: 34748155
[TBL] [Abstract][Full Text] [Related]
19. Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging.
Xiao J; Hu B; Cheng D; Shi H; Xiu Y
Nucl Med Commun; 2020 Sep; 41(9):933-941. PubMed ID: 32796482
[TBL] [Abstract][Full Text] [Related]
20. Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan.
Orozco-Gálvez O; Fernández-Codina A; Simó-Perdigo M; Pinal-Fernández I; Martínez-Valle F
Clin Nucl Med; 2021 Jun; 46(6):e307-e311. PubMed ID: 33630792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
